Dr. Alyssa Diamond Mohammed, MD

Dr. Mohammed practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Mohammed's NPI, 1164876843, was assigned on April 19, 2016. Dr. Mohammed graduated from Joe R. & Teresa Lozano Long School of Medicine in 2016. Dr. Mohammed holds Texas license BP10056246.

Dr. Mohammed's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Mohammed's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mohammed practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Mohammed's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mohammed is licensed in Texas.

Dmand AI lists acute diabetes, acute respiratory failure, bile duct problems, circulatory problems in extremities, electrolyte disorders, gastrointestinal infection, gastrointestinal inflammation and heart attack among the conditions Dr. Mohammed treats.

CMS data shows 590 Medicare services from Dr. Mohammed across 4 procedure codes in 2024, for 179 Medicare patients. Medicare paid $51,244 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 179 Medicare patients who saw Dr. Mohammed in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mohammed's median patient age at 70, with 43% women.

In 2024, Dr. Mohammed wrote 184 Medicare Part D claims for 78 patients. 91% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $63 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mohammed for performance year 2024, reported as part of a group. Dr. Mohammed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Mohammed, published from 2022 to 2024. The most frequent topics are Aftercare, COVID-19 and Patient Discharge. Dr. Mohammed has published most often in Support Care Cancer. Dr. Mohammed's most frequent co-authors are Kodwo Bosemefi Dickson, MD, Joanna-Grace Mayo Manzano, MD and Mayoora Muthu, DO.

Dr. Mohammed graduated from Joe R. & Teresa Lozano Long School of Medicine in 2016. Dr. Mohammed is a member of AOA.

Dr. Mohammed is in network with 4 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.